The compound inhibited HMGB1-mediated hyperpermeability and leukocyte migration in mice, and also decreased CLP-induced release of HMGB1, sepsis-related mortality and tissue injury in vivo (Lee et al., 2019). The gene discussed is HMGB1; the disease is Sepsis.